Patent details

EP0426390 Title: Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure.

Basic Information

Publication number:
EP0426390
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP903117554
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure.
French Title of Invention:
Procédé pour l'utilisation de (2-imidazoline-2-ylamino)-quinoxalines pour réduire ou maintenir la pression intraoculaire.
German Title of Invention:
Verfahren zur Verwendung von (2-Imidazolin-2-ylamino)-Chinoxalinen zur Senkung oder Stabilisierung des intraokulÄren Druckes.
SPC Number:

Dates

Filing date:
26/10/1990
Grant date:
10/05/1995
EP Publication Date:
10/05/1995
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/05/1991
EP B1 Publication Date:
10/05/1995
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
31/10/1995
Expiration date:
26/10/2010
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/10/1990
 
 

Name:
ALLERGAN INC.
Address:
2525 DUPONT DRIVE, P.O. BOX 19534, IRVINE, CALIFORNIA 92713-9534, United States (US)

Inventor

Name:
Gluchowski Charles
Address:
United States (US)

Priority

Priority Number:
429835
Priority Date:
31/10/1989
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/495;
Filing date Document type Number of pages